Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings07-12-2022
07-12-2022
Gland Pharma Ltd - 543245 - Intimation of Schedule of Analyst / Institutional Investor Meetings
Gland Pharma Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".05-12-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings01-12-2022
Buy Gland Pharma; target of Rs 2260: Sharekhan
Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2260 in its research report dated November 30, 2022.01-12-2022
Gland Pharma: Acquisition of Cenexi Group
Conference Call with Gland Pharma Management and Analysts on the company's recent acquisition. Listen to the full transcript.30-11-2022
Gland Pharma stock seen underperforming after acquiring France's Cenexi
Lack of near-term visibility on profitability for the core business is another concern about Indian firm30-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor Call Recording29-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on the Proposed Acquisition of Cenexi Group29-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the Proposed Acquisition of Cenexi Group29-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Acquisition
Proposed acquisition of Cenexi Group29-11-2022